Skip to main content
. 2020 Feb 15;11(2):42–51. doi: 10.4239/wjd.v11.i2.42

Table 1.

Clinical and biochemical features of the study subjects

Parameters PCOS (n = 72) Controls (n = 71) P value
Age (yr) 24.4 ± 5.2 24.25 ± 5.5 0.869
Menarche age (yr) 12.97 ± 1.9 12.86 ± 1.8 0.723
Ferriman-Gallwey Score 8.62 ± 6.2 2.32 ± 2.3 < 0.001
Systolic blood pressure (mm Hg) 109.24 ± 17.26 100.86 ±15.27 0.003
Diastolic blood pressure (mm Hg) 71.84 ± 14.11 64.96 ± 12.53 0.003
BMI (kg/m²) 25.23 ± 5.55 23.07 ± 4.52 0.013
WC (cm) 84.28 ± 13.94 78.63 ± 11.60 0.009
WHR 0.81 ± 0.06 0.80 ± 0.05 0.101
WHtR 0.51 ± 0.08 0.48 ± 0.07 0.018
Dominant Wrist Circumference (cm) 15.98 ± 1.15 15.53 ± 0.87 0.009
Non-Dominant Wrist Circumference (cm) 15.80 ± 1.18 15.33 ± 0.87 0.009
Weight (kg) 66.9 ± 16.3 60.8 ± 11.8 0.013
Body fat (%) 35.05 ± 9.6 32.37 ± 8 0.076
Muscle (%) 26.6 ± 4.5 27.9 ± 3 0.042
Visceral fat 4.67 ± 2 3.97 ± 1.7 0.031
Glucose (mg/dL) 86.51 ± 10.3 84.3 ± 8.04 0.155
Insulin (µU/L) 14.91 ± 15.4 6.34 ± 3.8 < 0.001
HOMA-IR (mol × µU/L²) 3.40 ± 4.03 1.33 ± 0.83 < 0.001

PCOS: Polycystic ovary syndrome; IR: Insulin resistance; BMI: Body mass index; WC: Waist circumference; WHR: Waist-to-hip ratio; WHtR: Waist-to-height ratio; HOMA-IR: Homeostasis Model Assessment of insulin resistance; n: Number of participants.